Inherited disorders of cholesterol biosynthesis

Citation
D. Haas et al., Inherited disorders of cholesterol biosynthesis, NEUROPEDIAT, 32(3), 2001, pp. 113-122
Citations number
55
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
NEUROPEDIATRICS
ISSN journal
0174304X → ACNP
Volume
32
Issue
3
Year of publication
2001
Pages
113 - 122
Database
ISI
SICI code
0174-304X(200106)32:3<113:IDOCB>2.0.ZU;2-Y
Abstract
Defects of cholesterol biosynthesis comprise a heterogeneous group of disor ders, most of which have only been recently described and more are likely t o follow in the near future. Mevalonic aciduria (MVA) and hyperimmunoglobulinemia D syndrome (HIDS) are due to allelic defects in mevalonate kinase, an enzyme located proximally i n the pathway of cholesterol and nonsterol isoprene biosynthesis. Clinicall y, patients affected with these disorders present with recurrent febrile at tacks. This is the only manifestation in most patients with HIDS, and, in t he case of classical mevalonic aciduria, is part of a severe multisystemic disease, including malformations, severe failure to thrive and neurological abnormalities. The other recognized defects of cholesterol biosynthesis ar e due to enzyme defects located distally in the pathway beyond the branchin g points of nonsterol isoprene biosynthesis and solely affecting cholestero l biosynthesis. Patients with these disorders all present with complex malf ormation syndromes involving different organ systems. The main characterist ics of CHILD syndrome and Conradi-Huenermann syndrome are skeletal defects and ichthyosiform skin involvement. Smith-Lemli-Opitz syndrome and desmoste rolosis are generalized malformation syndromes involving many different org ans including the central nervous system. The diagnosis of MVA and HIDS is based on determination of mevalonic acid i n urine followed by determination of enzyme activity, whereas the search fo r the distally located defects of cholesterol biosynthesis requires sterol analysis in blood or tissues by GCMS. Rational therapeutic approaches have been described for HIDS, MVA and Smith -Lemli-Opitz syndrome.